Avoro Capital Advisors LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Avoro Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $29.4 Million - $39 Million	250,000 New	250,000 $34.5 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $7.73 Million - $9.94 Million	100,000 Added 50.0%	300,000 $2.91 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $3.3 Million - $4.62 Million	-50,000 Reduced 20.0%	200,000 $2.19 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $28.1 Million - $38 Million	250,000 New	250,000 $5.46 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.